Friday, February 10, 2017 10:17:18 PM
Government of Canada
Search and menus
Search and menus
You are here:
HomeDrugs & Health ProductsDrug ProductsClinical Trials Database
Clinical trial information
From Health Canada
New search
Medical condition:
BLADDER CANCER
Study population:
ADULT FEMALE, ADULT MALE
Drug name:
TLD1433
Protocol title:
A PHASE IB TRIAL OF INTRAVESICAL PHOTODYNAMIC THERAPY IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER AT HIGH RISK OF PROGRESSION WHO ARE REFRACTORY TO THERAPY WITH BACILLUS CALMETTER-GUERIN (BCG) AND WHO ARE MEDICALLY UNFIT FOR OR REFUSE A CYSTECTOMY.
Protocol number:
TLD1433
Sponsor name:
THERALASE TECHNOLOGIES INC
Date of no objection letter:
2015-12-16
Control number:
189722
Trial status:
ONGOING
Date study started:
2016-12-08
Date study completed:
New search
Application information
Search tips
CTA terminology
Frequently asked questions
Related information
Drug product database
https://health-products.canada.ca/ctdb-bdec/search-recherche.do;jsessionid=2DB26640722BF56391640BC778863D08
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM